# Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

> **NCT06518655** · — · RECRUITING · sponsor: **ChromX Health** · enrollment: 3000 (estimated)

## Conditions studied

- Pulmonary Nodules, Multiple
- Pulmonary Nodules, Solitary
- Lung Cancer

## Interventions

- **OTHER:** Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system

## Key facts

- **NCT ID:** NCT06518655
- **Lead sponsor:** ChromX Health
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06518655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06518655, "Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06518655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*